Nicole L La Gruta Selected Research

Ligands

1/2022	Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice.
9/2005	Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole L La Gruta Research Topics

Disease

22	Infections 01/2023 - 06/2004
19	Human Influenza (Influenza) 11/2023 - 03/2004
4	Virus Diseases (Viral Diseases) 01/2022 - 12/2002
3	Neoplasms (Cancer) 01/2022 - 09/2005
2	Rheumatoid Arthritis 01/2021 - 11/2013
2	Autoimmune Diseases (Autoimmune Disease) 11/2017 - 10/2002
2	Celiac Disease (Celiac Sprue) 11/2015 - 05/2014
1	Fibrosis (Cirrhosis) 11/2021
1	Malaria 10/2020
1	Multiple Sclerosis 11/2017
1	Lymphopenia (Lymphocytopenia) 01/2014
1	Inflammation (Inflammations) 09/2005
1	Pneumonia (Pneumonitis) 03/2004
1	Gastritis 10/2002

Drug/Important Bio-Agent (IBA)

23	EpitopesIBA 11/2023 - 03/2004
8	AntigensIBA 10/2020 - 06/2004
8	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 10/2015 - 03/2004
7	Peptides (Polypeptides)IBA 10/2020 - 03/2004
6	CytokinesIBA 01/2023 - 05/2004
6	NucleoproteinsIBA 01/2019 - 05/2004
6	AcidsIBA 01/2019 - 03/2004
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2015 - 03/2004
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2017 - 11/2013
3	Amino Acids FDA Link 01/2013 - 04/2005
2	LigandsIBA 01/2022 - 09/2005
2	Histocompatibility Antigens Class IIBA 10/2020 - 12/2010
2	VaccinesIBA 01/2019 - 11/2007
2	GliadinIBA 11/2015 - 05/2014
2	Glutens (Glutelin)IBA 11/2015 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 01/2013
2	AutoantigensIBA 11/2013 - 10/2002
2	Bromodeoxyuridine (BrdU)IBA 01/2013 - 07/2012
2	Glycoproteins (Glycoprotein)IBA 01/2006 - 03/2004
2	Indicators and Reagents (Reagents)IBA 06/2004 - 12/2002
1	HLA-A Antigens (HLA-A)IBA 11/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	CTLA-4 AntigenIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	ChromatinIBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	CollagenIBA 11/2021
1	C.I. direct red 80IBA 11/2021
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2021
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2020
1	ribosomal protein L6IBA 10/2020
1	Peptide LibraryIBA 11/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 11/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	CD40 Ligand (CD40L)IBA 01/2013
1	LipopeptidesIBA 08/2011
1	SolventsIBA 08/2010
1	PerforinIBA 09/2008
1	Granzymes (Granzyme)IBA 09/2008
1	Immunologic Factors (Immunomodulators)IBA 02/2007
1	Interleukin-11 (Interleukin 11)IBA 09/2005
1	InterleukinsIBA 09/2005
1	Interleukin-6 (Interleukin 6)IBA 09/2005
1	Matrix Metalloproteinases (MMPs)IBA 09/2005
1	Arginine (L-Arginine)FDA Link 04/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2004
1	Coloring Agents (Dyes)IBA 12/2002
1	Adenosine Triphosphatases (ATPase)IBA 10/2002
1	H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)IBA 10/2002

Therapy/Procedure

1	Immunotherapy 01/2022
1	Therapeutics 01/2022
1	Gluten-Free Diet 11/2015